Rising Forecast for Next-Generation Antibody Therapeutics Market: CAGR of 11.8% by 2025 and 10.9% by 2029

Follow the rapid growth of this emerging market, driven by developments in immunotherapies, biosimilar antibodies, nanobodies, and more.

What Is The Projected Market Size Of The Global Next-Generation Antibody Therapeutics Market And Its Growth Rate?
The global next-generation antibody therapeutics market presents substantial growth potential:
• Market value climbed from $6.82 billion in 2024 to an estimated $7.63 billion in 2025, reflecting a CAGR of 11.8%.
• The market size is projected to reach $11.52 billion by 2029, with an expected CAGR of 10.9%.
• Driving growth between 2025 and 2029 are factors such as biosimilars development, bispecific antibodies, nanobody development, patient-centric approaches, immunomodulatory antibodies, and expanded applications in autoimmune diseases.

What Is Driving The Growth In The Next-Generation Antibody Therapeutics Market?
A key factor propelling growth in the next-generation antibody therapeutics market is the increasing incidence of chronic diseases. Chronic diseases, which require ongoing medical care and often limit daily activities, are increasingly being treated with next-generation antibody therapeutics. For example, it was projected that the population aged 50 years and older with at least one chronic disease will surge by 99.5% by 2050, rising to 142.66 million. The correlation between rising chronic disease prevalence and the market growth of next-generation antibody therapeutics is clear and decisive.

Request a Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12678&type=smp

Who Are the Key Players Driving Next-Generation Antibody Therapeutics Market Growth?
Crucial players in the next-generation antibody therapeutics market include:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Bayer AG
• Bristol-Myers Squibb Company
• AstraZeneca plc
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Gilead Sciences Inc.
• Boehringer Ingelheim International GmbH
• Amgen Inc.
• Moderna Inc.
• BioNTech SE
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Celgene Corporation
• Lonza Group AG
• Catalent Inc.
• Genentech Inc.
• Kyowa Hakko Kirin Co. Ltd.
• Samsung Biologics
• WuXi Biologics
• Seagen Inc.
• Seattle Genetics Inc.
• Xencor Inc.
• ImmunoGen Inc.

What Are The Key Trends In The Next-Generation Antibody Therapeutics Market?
Key trends in the forecast period include:
• Advancements in antibody engineering
• Increase in adoption of digital technologies in antibody design
• Enhanced industry collaborations
• Innovation in drug delivery systems
• Incorporation of real-world evidence in antibody development

What Are The Segments Of The Global Next-Generation Antibody Therapeutics Market?
The global next-generation antibody therapeutics market is segmented as follows:
1) By Types Of Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Biospecific Antibodies, Antibody-Drug Conjugates, others
2) By Therapeutic Area: Oncology, Autoimmune Diseases, Infectious Diseases, Neurodegenerative Disorders, others
3) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, others

Which Region Leads The Next-Generation Antibody Therapeutics Market?
North America was the largest regional market for Next-Generation Antibody Therapeutics in 2024. However, Asia-Pacific is expected to be the fastest-growing region over the forecast period. Other regions featured in this market report include Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/next-generation-antibody-therapeutics-global-market-report

What Is Covered In The Next-Generation Antibody Therapeutics Market Global Market Report?
- Market Size Analysis: Analyze the Next-Generation Antibody Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Next-Generation Antibody Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Next-Generation Antibody Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Next-Generation Antibody Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=12678&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.